Genetic polymorphisms of the natriuretic peptide system in the pathogenesis of cardiovascular disease: What lies on the horizon?

Clinical Chemistry

Volumn 55, Issue 5, 2009, Pages 878-887

  Vassalle, Cristina ^a,b   Andreassi, Maria Grazia ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b FONDAZIONE TOSCANA GABRIELE MONASTERIO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NATRIURETIC FACTOR; NATRIURETIC PEPTIDE RECEPTOR C;

AMINO ACID SUBSTITUTION; CARDIOVASCULAR DISEASE; CHROMOSOMAL LOCALIZATION; GENE LOCATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; PATHOGENESIS; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; GENETIC VARIATION; HUMANS; NATRIURETIC PEPTIDES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 65949090940     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.120832     Document Type: Review

References (80)

1. de Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981;28:89-94. (Pubitemid 11184926)
2. Clerico A, Recchia FA, Passino C, Emdin M. Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications. Am J Physiol Heart Circ Physiol 2006;290:H17-29.
3. Potter LR, Abbey-Hosch S, Dickey DM. Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 2006;27:47-72. (Pubitemid 43228238)
4. Lang RE, Unger T, Ganten D. Atrial natriuretic peptide: a new factor in blood pressure control. J Hypertens 1987;5:255-271 (Pubitemid 17110033)
5. Nicholls MG, Espiner EA, Ikram H, Crozier IG, Richards AM. Atrial natriuretic peptide in human hypertension. Eur Heart J 1987;8 Suppl B:123-128
6. Pitzalis MV, Iacoviello M, Massari F, et al. Influence of gender and family history of hypertension on autonomic control of heart rate, diastolic function and brain natriuretic peptide. J Hypertens 2001;19:143-148
7. Mo R, Myking OL, Lund-Johansen P, Omvik P. The Bergen Blood Pressure Study: inappropriately low levels of circulating atrial natriuretic peptide in offspring of hypertensive families. Blood Press 1994;3:223-230 (Pubitemid 24257769)
8. Clarkson PB, Wheeldon NM, Macleod C, Coutie W, MacDonald TM. Acute effects of atrial natriuretic peptide on left ventricular diastolic function: a pulsed wave Doppler study in man. Eur Heart J 1995;16:1710-1715 (Pubitemid 26037807)
9. Clarkson PB, Wheeldon NM, Macleod C, Coutie W, MacDonald TM. Brain natriuretic peptide: effect on left ventricular filling patterns in healthy subjects. Clin Sci (Lond) 1995;88:159-164
10. Garcia R, Thibault G, Cantin M. Correlation between cardiac hypertrophy and plasma levels of atrial natriuretic factor in non-spontaneous models of hypertension in the rat. Biochem Biophys Res Commun 1987;145:532-541 (Pubitemid 17088469)
11. Jernberg T, James S, Lindahl B, Johnston N, Stridsberg M, Venge P, Wallentin L. Natriuretic peptides in unstable coronary artery disease. Eur Heart J 2004;25:1486-1493 (Pubitemid 39165626)
12. Daniels LB, Maisel AS. Natriuretic peptides. J Am Coll Cardiol 2007;50:2357-2368 (Pubitemid 50011582)
13. Casco VH, Veinot JP, Kuroski de Bold ML, Masters RG, Stevenson MM, de Bold AJ. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem 2002;50:799-809. (Pubitemid 34721448)
14. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:25-146.
15. Doust JA, Glasziou PP, Pietrzak E, Dobson AJ. A. systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Arch Intern Med 2004;164:1978-1984. (Pubitemid 39390553)
16. Clerico A, Fontana M, Zyw L, Passino C, Emdin M. Comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP immunoassays in chronic and acute heart failure: a systematic review. Clin Chem 2007;53:813-822 (Pubitemid 46744235)
17. Doust JA, Pietrzak E, Dobson A, Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 2005;330:625. (Pubitemid 40444756)
18. Jourdain P, Jondeau G, Funck F, Gueffet P, Le Helloco A, Donal E, et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP Multicenter Study. J Am Coll Cardiol 2007;49:1733-1739
19. Lainchbury JG, Troughton RW, Frampton CM, Yandle TG, Hamid A, Nicholls MG, Richards AM. NTproBNP-guided drug treatment for chronic heart failure: design and methods in the "BATTLESCARRED" trial. Eur J Heart Fail 2006;8:532-538
20. Brunner-La Rocca HP, Buser PT, Schindler R, Bernheim A, Rickenbacher P, Pfisterer M. Management of elderly patients with congestive heart failure - design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF). Am Heart J 2006;151:949-955
21. Flynn TG, Davies PL. The biochemistry and molecular biology of atrial natriuretic factor. Biochem J 1985;232:313-321 (Pubitemid 16210760)
22. Barley J, Carter ND, Cruickshank JK, Jeffery S, Smith A, Charlett A, Webb DJ. Renin and atrial natriuretic peptide restriction fragment length polymorphisms: association with ethnicity and blood pressure. J Hypertens 1991;9:993-996
23. Ramasawmy R, Kotea N, Lu CY, Sayada C, Baligadoo S, Krishnamoorthy R. Investigation of the polymorphic ScaI site by a PCR-based assay at the human atrial natriuretic peptides (hANP) gene locus. Hum Genet 1992;90:323-324
24. Ramasawmy R, Kotea N, Lu C, Sayada C, Baligadoo S, Krishnamoorthy R. A new polymorphic restriction site at the human atrial natriuretic peptide (hANP) gene locus. Hum Genet 1993;91:509-510 (Pubitemid 23220106)
25. Ramasawmy R, Lu CY, Kok-Sun N, Kotea N, Baligadoo S, Krishnamoorthy R. Insertion/deletion polymorphism within a polyadenylate stretch at the human atrial natriuretic peptides (hANP) gene locus. Hum Genet 1994;93:355-356 (Pubitemid 24066946)
26. Schmidt S, Blüthner M, Giessel R, Strojek K, Bergis KH, Grzeszczak W, Ritz E. A polymorphism in the gene for the atrial natriuretic peptide and diabetic nephropathy. Diabetic Nephropathy Study Group. Nephrol Dial Transplant 1998;13:1807-1810.
27. Rubattu S, Ridker P, Stampfer MJ, Volpe M, Hennekens CH, Lindpaintner K. The gene encoding atrial natriuretic peptide and the risk of human stroke. Circulation 1999;100:1722-1726 (Pubitemid 29485255)
28. Nannipieri M, Penno G, Pucci L, Colhoun H, Motti C, Bertacca A, et al. Pronatriodilatin gene polymorphisms, microvascular permeability, and diabetic nephropathy in type 1 diabetes mellitus. J Am Soc Nephrol 1999;10:1530-1541
29. Rubattu S, Bigatti G, Evangelista A, Lanzani C, Stanzione R, Zagato L, et al. Association of atrial natriuretic peptide and type A natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension. J Am Coll Cardiol 2006;48:499-505.
30. Kato N, Sugiyama T, Morita H, Nabika T, Kurihara H, Yamori Y, Yazaki Y. Genetic analysis of the atrial natriuretic peptide gene in essential hypertension. Clin Sci (Lond) 2000;98:251-258 (Pubitemid 30145230)
31. Nannipieri M, Manganiello M, Pezzatini A, De Bellis A, Seghieri G, Ferrannini E. Polymorphisms in the hANP (human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension 2001;37:1416-1422 (Pubitemid 34225385)
32. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Kunimoto M, Uwabo J, et al. Association study between the variants of the human ANP gene and essential hypertension. Hypertens Res 2001;24:291-294
33. Kato N, Ikeda K, Nabika T, Morita H, Sugiyama T, Gotoda T, et al. Evaluation of the atrial natriuretic peptide gene in stroke. Atherosclerosis 2002;163:279-286
34. Gruchala M, Ciećwierz D, Wasag B, Targoń ski R, Dubaniewicz W, Nowak A, et al. Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease. Am Heart J 2003;145:125-131
35. Nannipieri M, Posadas R, Williams K, Politi E, Gonzales-Villalpando C, Stern MP, Ferrannini E. Association between polymorphisms of the atrial natriuretic peptide gene and proteinuria: a population-based study. Diabetologia 2003;46:429-432 (Pubitemid 36547601)
36. Roussel R, Trégouët DA, Hadjadj S, Jeunemaître X, Marre M. Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. Diabetes 2004;53:1394-1398 (Pubitemid 38569028)
37. Rubattu S, Stanzione R, Di Angelantonio E, Zanda B, Evangelista A, Tarasi D, et al. Atrial natriuretic peptide gene polymorphisms and risk of ischemic stroke in humans. Stroke 2004;35:814-818
38. Zhang S, Mao G, Zhang Y, Tang G, Wen Y, Hong X, et al. Association between human atrial natriuretic peptide Val7Met polymorphism and baseline blood pressure, plasma trough irbesartan concentrations, and the antihypertensive efficacy of irbesartan in rural Chinese patients with essential hypertension. Clin Ther 2005;27:1774-1784
39. Conen D, Glynn RJ, Buring JE, Ridker PM, Zee RY. Natriuretic peptide precursor a gene polymorphisms and risk of blood pressure progression and incident hypertension. Hypertension 2007;50:1114-1119 (Pubitemid 350172934)
40. Lee C, Kong M. An interactive association of common sequence variants in the neuropeptide Y gene with susceptibility to ischemic stroke. Stroke 2007;38:2663-2669 (Pubitemid 47494001)
41. Vassalle C, Andreassi MG, Prontera C, Fontana M, Zyw L, Passino C, Emdin M. Influence of ScaI and natriuretic peptide (NP) clearance receptor polymorphisms of the NP System on NP concentration in chronic heart failure. Clin Chem 2007;53:1886-1890. (Pubitemid 350036031)
42. Iemitsu M, Maeda S, Otsuki T, Sugawara J, Kuno S, Ajisaka R, Matsuda M. Arterial stiffness, physical activity, and atrial natriuretic peptide gene polymorphism in older subjects. Hypertens Res 2008;31:767-774
43. Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker-Foster C, Arnett DK. Pharmacogenetic association of the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA 2008;299:296-307.
44. Sudoh T, Maekawa K, Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for human brain natriuretic peptide. Biochem Biophys Res Commun 1989;159:1427-1434 (Pubitemid 19101141)
45. LaPointe MC, Wu G, Garami M, Yang XP, Gardner DG. Tissue specific expression of the human brain natriuretic peptide gene in cardiac myocytes. Hypertension 1996;27:715-722 (Pubitemid 26084638)
46. Tiret L, Mallet C, Poirier O, Nicaud V, Millaire A, Bouhour JB, et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. J Am Coll Cardiol 2000;35:29-35. (Pubitemid 30061255)
47. Meirhaeghe A, Sandhu MS, McCarthy MI, de Groote P, Cottel D, Arveiler D, et al. Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet 2007;16:1343-1350
48. Takeishi Y, Toriyama S, Takabatake N, Shibata Y, Konta T, Emi M, et al. Linkage disequilibrium analyses of natriuretic peptide precursor B locus reveal risk haplotype conferring high plasma BNP levels. Biochem Biophys Res Commun 2007;362:480-484
49. Lanfear DE, Stolker JM, Marsh S, Rich MW, McLeod HL. Genetic variation in the B-type natriuretic peptide pathway affects BNP levels. Cardiovasc Drugs Ther 2007;21:55-62. (Pubitemid 46594988)
50. Lajer M, Tarnow L, Jorsal A, Parving HH. Polymorphisms in the B-type natriuretic peptide (BNP) gene are associated with NT-proBNP levels but not with diabetic nephropathy or mortality in type 1 diabetic patients. Nephrol Dial Transplant 2007;22:3235-3239 (Pubitemid 350202546)
51. Kosuge K, Soma M, Nakayama T, Aoi N, Sato M, Izumi Y, Matsumoto K. A novel variable number of tandem repeat of the natriuretic peptide precursor B gene's 5′-flanking region is associated with essential hypertension among Japanese females. Int J Med Sci 2007;4:146-152 (Pubitemid 46795182)
52. Rahmutula D, Nakayama T, Soma M, Kosuge K, Aoi N, Izumi Y, et al. Structure and polymorphisms of the human natriuretic peptide receptor C gene. Endocrine 2002;17:85-90.
53. Sarzani R, Dessì-Fulgheri P, Salvi F, Serenelli M, Spagnolo D, Cola G, et al. A novel promoter variant of the natriuretic peptide clearance receptor gene is associated with lower atrial natriuretic peptide and higher blood pressure in obese hypertensives. J Hypertens 1999;17:1301-1305
54. Pitzalis MV, Sarzani R, Dessì-Fulgheri P, Iacoviello M, Forleo C, Lucarelli K, et al. Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype. J Hypertens 2003;21:1445-1446
55. Lee JK, Kim HT, Cho SM, Kim KH, Jin HJ, Ryu GM, et al. Characterization of 458 single nucleotide polymorphisms of disease candidate genes in the Korean population. J Hum Genet 2003;48:213-216
56. Aoi N, Soma M, Nakayama T, Rahmutula D, Kosuge K, Izumi Y, Matsumoto K. Variable number of tandem repeat of the 5′-flanking region of type-C human natriuretic peptide receptor gene influences blood pressure levels in obesity-associated hypertension. Hypertens Res 2004;27:711-716 (Pubitemid 40045509)
57. Sarzani R, Strazzullo P, Salvi F, Iacone R, Pietrucci F, Siani A, et al. Natriuretic peptide clearance receptor alleles and susceptibility to abdominal adiposity. Obes Res 2004;12:351-356
58. Takahashi Y, Nakayama T, Soma M, Izumi Y, Kanmatsuse K. Organization of the human natriuretic peptide receptor A gene. Biochem Biophys Res Commun 1998;246:736-739 (Pubitemid 28420927)
59. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, et al. Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension. Circ Res 1999;84:605-610
60. Suzuki T, Yamazaki T, Yazaki Y. The role of the natriuretic peptides in the cardiovascular system. Cardiovasc Res 2001;51:489-494 (Pubitemid 32718597)
61. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Sato M, Uwabo J, et al. Nucleotide sequence of the 5′-flanking region of the type A human natriuretic peptide receptor gene and association analysis using a novel microsatellite in essential hypertension. Am J Hypertens 1999;12:1144-1148
62. Nakayama T, Soma M, Takahashi Y, Rehemudula D, Kanmatsuse K, Furuya K. Functional deletion mutation of the 5′-flanking region of type A human natriuretic peptide receptor gene and its association with essential hypertension and left ventricular hypertrophy in the Japanese. Circ Res 2000;86:841-845 (Pubitemid 30246980)
63. Nakayama T, Soma M, Mizutani Y, Xinjuan X, Honye J, Kaneko Y, et al. A novel missense mutation of exon 3 in the type A human natriuretic peptide receptor gene: possible association with essential hypertension. Hypertens Res 2002;25:395-401.
64. Nakayama T, Soma M, Saito S, Honye J, Sato M, Aoi N, et al. Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction. Med Sci Monit 2003;9:CR505-10.
65. Palmer BR, Frampton CM, Richards AM, Cameron VA, Nakayama T. Absence of a NPR-A gene functional deletion allele in a postmyocardial infarction cohort from New Zealand. Circ Res 2004;94:e86.
66. Knowles JW, Erickson LM, Guy VK, Sigel CS, Wilder JC, Maeda N. Common variations in non-coding regions of the human natriuretic peptide receptor A gene have quantitative effects. Hum Genet 2003;112:62-70. (Pubitemid 36869117)
67. Weber M, Burian M, Dragutinovic I, Moellmann H, Nef H, Elsaesser A, et al. Genetic polymorphism of the type A human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system. Eur J Heart Fail 2008;10:482-489
68. Usami S, Kishimoto I, Saito Y, Harada M, Kuwahara K, Nakagawa Y, et al. Association of CT dinucleotide repeat polymorphism in the 5′-flanking region of the guanylyl cyclase (GC): a gene with essential hypertension in the Japanese. Hypertens Res 2008;31:89-96.
69. Rahmutula D, Nakayama T, Soma M, Sato M, Izumi Y, Kanmatsuse K, Ozawa Y. Systematic screening of type B human natriuretic peptide receptor gene polymorphisms and association with essential hypertension. J Hum Hypertens 2001;15:471-474 (Pubitemid 32640262)
70. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, et al. An insertion/deletion polymorphism in intron 18 of the type B human natriuretic peptide receptor gene is not associated with cerebral infarction. Hypertens Res 2000;23:173-176
71. Rahmutula D, Nakayama T, Soma M, Takahashi Y, Uwabo J, Sato M, et al. A C2077T polymorphism of the type B human natriuretic peptide receptor gene is not associated with myocardial infarction. Med Sci Monit 2000;6:1056-1060
72. Ono K, Mannami T, Baba S, Tomoike H, Suga S, Iwai N. A single-nucleotide polymorphism in C-type natriuretic peptide gene may be associated with hypertension. Hypertens Res 2002;25:727-730 (Pubitemid 35153761)
73. Risch NJ. Searching for genetic determinants in the new millennium. Nature (Lond) 2000;405:847-856 (Pubitemid 30407863)
74. Humphries SE. Genetic strategies for common complex disorders: ischaemic heart disease as an example. In: Bishop T, Sham P, eds. Analysis of multifactorial disease. Oxford: BIOS Scientific Publishers; 2000. p 309-332
75. Goldstein DB, Tate SK, Sisodiya SM. Pharmacogenetics goes genomic. Genetics 2005;4:937-947 (Pubitemid 37474641)
76. Davis BR, Ford CE, Boerwinkle E, Arnett D, Eckfeldt J, Black H. Imputing gene-treatment interactions when the genotype distribution is unknown using case-only and putative placebo analyses: a new method for the Genetics of Hypertension Associated Treatment (GenHAT) study. Statist Med 2004;23:2413-2427 (Pubitemid 39136250)
77. Little J, Sharp L, Khoury MJ, Bradley L, Gwinn M. The epidemiologic approach to pharmacogenomics. Am J Pharmacogenomics 2005;5:1-20. (Pubitemid 40803828)
78. Clayton D, McKeigue PM. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet 2001;358:1356-1360 (Pubitemid 33016504)
79. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol 1996;144:207-213
80. Manfredi S, Calvi D, del Fiandra M, Botto N, Biagini A, Andreassi MG. Glutathione S-transferase T1- and M1-null genotypes and coronary artery disease risk in patients with Type 2 diabetes mellitus. Pharmacogenomics 2009;10:29-34.